Should You Investigate Repligen Corporation (NASDAQ:RGEN) At US$126?
Repligen Corporation (NASDAQ:RGEN), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Citigroup r
Express News | Repligen Corp : Deutsche Bank Raises to Buy From Hold; Cuts Target Price to $155 From $180
Repligen Raised to Buy From Hold by Deutsche Bank
Repligen Raised to Buy From Hold by Deutsche Bank
Deutsche Numis Upgrades Repligen(RGEN.US) to Buy Rating, Cuts Target Price to $155
Deutsche Numis analyst Justin Bowers upgrades $Repligen(RGEN.US)$ to a buy rating, and adjusts the target price from $180 to $155.According to TipRanks data, the analyst has a success rate of 49.5% an
Deutsche Bank Upgrades Repligen to Buy, Lowers Price Target to $155
Deutsche Bank analyst Justin Bowers upgrades Repligen (NASDAQ:RGEN) from Hold to Buy and lowers the price target from $180 to $155.
RBC Cuts Price Target on Repligen to $190 From $221, Maintains Outperform Rating
Repligen (RGEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $165 to $225.
Express News | Repligen Corp : RBC Cuts Target Price to $190 From $221
Top 3 Health Care Stocks That Could Blast Off In June
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
What Is Repligen Corporation's (NASDAQ:RGEN) Share Price Doing?
Express News | Repligen Corp : Guggenheim Initiates Coverage With Neutral Rating
Guggenheim Initiates Repligen(RGEN.US) With Hold Rating
Guggenheim analyst Subbu Nambi initiates coverage on $Repligen(RGEN.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 0.0% and a total average return of 0.0% over t
Repligen Initiated at Neutral by Guggenheim
Repligen Initiated at Neutral by Guggenheim
Guggenheim Initiates Coverage On Repligen With Neutral Rating
Guggenheim analyst Subbu Nambi initiates coverage on Repligen (NASDAQ:RGEN) with a Neutral rating.
Repligen Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 — Guggenheim Initiates Coverage On → Neutral 05/02/2024 60.84% JP Morgan $230 → $200 Maintains
What You Can Learn From Repligen Corporation's (NASDAQ:RGEN) P/S After Its 27% Share Price Crash
Unfortunately for some shareholders, the Repligen Corporation (NASDAQ:RGEN) share price has dived 27% in the last thirty days, prolonging recent pain. Instead of being rewarded, shareholders who ha
Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN)
Repligen(RGEN.US) Director Buys US$201.78K in Common Stock
$Repligen(RGEN.US)$ Director Madaus Martin D purchased 1,615 shares of common stock on Jun 14, 2024 at an average price of $124.94 for a total value of $201.78K.Source: Announcement What is statement
Repligen(RGEN.US) Director Buys US$150.54K in Common Stock
$Repligen(RGEN.US)$ Director BARTHELEMY NICOLAS purchased 1,200 shares of common stock on Jun 14, 2024 at an average price of $125.45 for a total value of $150.54K.Source: Announcement What is stateme